vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and CARRIAGE SERVICES INC (CSV). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($191.2M vs $105.5M, roughly 1.8× CARRIAGE SERVICES INC). On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (57.4% vs 8.0%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (48.1% CAGR vs 1.0%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.
AXSM vs CSV — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $191.2M | $105.5M |
| Net Profit | — | $12.3M |
| Gross Margin | — | 34.8% |
| Operating Margin | -33.1% | 23.3% |
| Net Margin | — | 11.6% |
| Revenue YoY | 57.4% | 8.0% |
| Net Profit YoY | — | 24.5% |
| EPS (diluted) | — | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $191.2M | — | ||
| Q4 25 | $196.0M | $105.5M | ||
| Q3 25 | $171.0M | $102.7M | ||
| Q2 25 | $150.0M | $102.1M | ||
| Q1 25 | $121.5M | $107.1M | ||
| Q4 24 | $118.8M | $97.7M | ||
| Q3 24 | $104.8M | $100.7M | ||
| Q2 24 | $87.2M | $102.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-28.6M | $12.3M | ||
| Q3 25 | $-47.2M | $6.6M | ||
| Q2 25 | $-48.0M | $11.7M | ||
| Q1 25 | $-59.4M | $20.9M | ||
| Q4 24 | $-74.9M | $9.9M | ||
| Q3 24 | $-64.6M | $9.9M | ||
| Q2 24 | $-79.3M | $6.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 34.8% | ||
| Q3 25 | — | 35.3% | ||
| Q2 25 | — | 35.2% | ||
| Q1 25 | — | 35.3% | ||
| Q4 24 | — | 34.4% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 36.2% |
| Q1 26 | -33.1% | — | ||
| Q4 25 | -13.8% | 23.3% | ||
| Q3 25 | -27.0% | 17.0% | ||
| Q2 25 | -24.5% | 23.5% | ||
| Q1 25 | -46.9% | 29.5% | ||
| Q4 24 | -61.1% | 21.6% | ||
| Q3 24 | -59.8% | 22.7% | ||
| Q2 24 | -89.5% | 18.0% |
| Q1 26 | — | — | ||
| Q4 25 | -14.6% | 11.6% | ||
| Q3 25 | -27.6% | 6.4% | ||
| Q2 25 | -32.0% | 11.5% | ||
| Q1 25 | -48.9% | 19.5% | ||
| Q4 24 | -63.1% | 10.1% | ||
| Q3 24 | -61.7% | 9.8% | ||
| Q2 24 | -91.0% | 6.1% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.55 | $0.76 | ||
| Q3 25 | $-0.94 | $0.41 | ||
| Q2 25 | $-0.97 | $0.74 | ||
| Q1 25 | $-1.22 | $1.34 | ||
| Q4 24 | $-1.54 | $0.62 | ||
| Q3 24 | $-1.34 | $0.63 | ||
| Q2 24 | $-1.67 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $305.1M | $1.7M |
| Total DebtLower is stronger | $70.0M | — |
| Stockholders' EquityBook value | — | $254.8M |
| Total Assets | $713.6M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $305.1M | — | ||
| Q4 25 | $322.9M | $1.7M | ||
| Q3 25 | $325.3M | $1.2M | ||
| Q2 25 | $303.0M | $1.4M | ||
| Q1 25 | $300.9M | $4.6M | ||
| Q4 24 | $315.4M | $1.2M | ||
| Q3 24 | $327.3M | $1.3M | ||
| Q2 24 | $315.7M | $1.5M |
| Q1 26 | $70.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $88.3M | $254.8M | ||
| Q3 25 | $73.7M | $242.1M | ||
| Q2 25 | $73.1M | $235.4M | ||
| Q1 25 | $53.2M | $223.1M | ||
| Q4 24 | $57.0M | $208.6M | ||
| Q3 24 | $92.9M | $198.1M | ||
| Q2 24 | $102.9M | $187.9M |
| Q1 26 | $713.6M | — | ||
| Q4 25 | $689.8M | $1.3B | ||
| Q3 25 | $669.3M | $1.3B | ||
| Q2 25 | $639.8M | $1.3B | ||
| Q1 25 | $596.7M | $1.3B | ||
| Q4 24 | $568.5M | $1.3B | ||
| Q3 24 | $561.5M | $1.3B | ||
| Q2 24 | $548.2M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $14.1M |
| Free Cash FlowOCF − Capex | — | $6.2M |
| FCF MarginFCF / Revenue | — | 5.9% |
| Capex IntensityCapex / Revenue | — | 7.5% |
| Cash ConversionOCF / Net Profit | — | 1.15× |
| TTM Free Cash FlowTrailing 4 quarters | — | $40.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $14.1M | ||
| Q3 25 | $1.0M | $24.7M | ||
| Q2 25 | $-32.4M | $8.1M | ||
| Q1 25 | $-43.4M | $13.8M | ||
| Q4 24 | $-26.2M | $9.3M | ||
| Q3 24 | $-18.6M | $20.9M | ||
| Q2 24 | $-30.1M | $2.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $6.2M | ||
| Q3 25 | $988.0K | $18.0M | ||
| Q2 25 | $-32.4M | $5.2M | ||
| Q1 25 | $-43.7M | $10.6M | ||
| Q4 24 | $-26.2M | $4.9M | ||
| Q3 24 | $-18.7M | $16.2M | ||
| Q2 24 | $-30.2M | $-1.4M |
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | 5.9% | ||
| Q3 25 | 0.6% | 17.5% | ||
| Q2 25 | -21.6% | 5.1% | ||
| Q1 25 | -36.0% | 9.9% | ||
| Q4 24 | -22.1% | 5.0% | ||
| Q3 24 | -17.9% | 16.1% | ||
| Q2 24 | -34.6% | -1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 7.5% | ||
| Q3 25 | 0.0% | 6.5% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 0.3% | 3.0% | ||
| Q4 24 | 0.0% | 4.5% | ||
| Q3 24 | 0.1% | 4.6% | ||
| Q2 24 | 0.1% | 3.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.15× | ||
| Q3 25 | — | 3.76× | ||
| Q2 25 | — | 0.69× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | — | 2.11× | ||
| Q2 24 | — | 0.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
